Works matching IS 03407004 AND DT 2024 AND VI 73 AND IP 5
Results: 20
Dual-loss of PBRM1 and RAD51 identifies hyper-sensitive subset patients to immunotherapy in clear cell renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03681-x
- By:
- Publication type:
- Article
Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03692-8
- By:
- Publication type:
- Article
Bifidobacterium modulation of tumor immunotherapy and its mechanism.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03665-x
- By:
- Publication type:
- Article
The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03656-y
- By:
- Publication type:
- Article
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03674-w
- By:
- Publication type:
- Article
DR30318, a novel tri-specific T cell engager for Claudin 18.2 positive cancers immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03673-x
- By:
- Publication type:
- Article
TGF-β1 and TGF-βR1 variants are associated with clinical outcomes in smoking-related head and neck cancer patients treated with chemoradiation through modulating microRNA-mediated regulation.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03672-y
- By:
- Publication type:
- Article
Characterization of a novel anti-PVRIG antibody with Fc-competent function that exerts strong antitumor effects via NK activation in preclinical models.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03671-z
- By:
- Publication type:
- Article
IL-2 promotes expansion and intratumoral accumulation of tumor infiltrating dendritic cells in pancreatic cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03669-7
- By:
- Publication type:
- Article
Prenatal inflammation exposure accelerates lung cancer tumorigenesis in offspring mouse: possible links to IRE1α/XBP1-mediated M2-like polarization of TAMs and PD-L1 up-expression.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03666-w
- By:
- Publication type:
- Article
IL7 in combination with radiotherapy stimulates a memory T-cell response to improve outcomes in HNSCC models.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03664-y
- By:
- Publication type:
- Article
Efficacy of immune checkpoint inhibitors differs in various status of carcinoma: a study based on 29 cohorts with 3255 participants.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03663-z
- By:
- Publication type:
- Article
23-Hydroxybetulinic acid attenuates 5-fluorouracil resistance of colorectal cancer by modulating M2 macrophage polarization via STAT6 signaling.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03662-0
- By:
- Publication type:
- Article
Lipid droplets-related Perilipin-3: potential immune checkpoint and oncogene in oral squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03659-9
- By:
- Publication type:
- Article
PGRN inhibits CD8<sup>+</sup>T cell recruitment and promotes breast cancer progression by up-regulating ICAM-1 on TAM.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03655-z
- By:
- Publication type:
- Article
Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03654-0
- By:
- Publication type:
- Article
The radiomics nomogram predicts the prognosis of pancreatic cancer patients with hepatic metastasis after chemoimmunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03644-2
- By:
- Publication type:
- Article
Targeting osteosarcoma with canine B7-H3 CAR T cells and impact of CXCR2 Co-expression on functional activity.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03642-4
- By:
- Publication type:
- Article
SFRP1 decreases WNT-Mediated M2 macrophage marker expression in breast tissue.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03638-0
- By:
- Publication type:
- Article
circFTO from M2 macrophage-derived small extracellular vesicles (sEV) enhances NSCLC malignancy by regulation miR-148a-3pPDK4 axis.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03634-4
- By:
- Publication type:
- Article